#cvs health

2 stories

#2026 earnings #aetna #analyst targets #artificial intelligence #chief technology officer #data integration #drug pricing #enterprise software #executives of the year #firdaus bhathena #forward p/e #nfl

CVS Shares Trade Below Wall Street Targets
CVS Health stock trades near $94, 19% below analyst target and 50% below model's $141 base case
Yahoo Finance · 1m
S&P Global's new tech chief transforms data and AI
Firdaus Bhathena brings startup mentality to financial data giant's biggest transformation yet.
TIME · 1m